A. Paudel, O. Mammadov, E. Ekicibaşi, N. Mammadov, Ararso Kedir Jima
{"title":"重症监护病房患者在生命最后几个小时的心电图变化:我们可以使用这些参数作为预后指标吗?","authors":"A. Paudel, O. Mammadov, E. Ekicibaşi, N. Mammadov, Ararso Kedir Jima","doi":"10.5336/cardiosci.2020-74783","DOIUrl":null,"url":null,"abstract":"ABS TRACT Objective: QRS amplitude attenuation and prolonged QRS duration has been associated with increased mortality in various clinical conditions including critical care patients and general population. Relative bradycardia has been found to be associated with lower mortality in patients with septic shock, but there are no studies in literature evaluating the electrocardiographic (ECG) changes and changes in heart rate (HR) just before death. Our aim of this study is to calculate the gradual changes in these parameters in the last hours of life from II derivation telemetry records. Material and Methods: We included 30 patients who died in intensive care unit irrespective of their diagnosis during admission and follow up. HR, QRS amplitude and QRS duration were analysed from the telemetry recordings obtained from the last 10 hours of their life. Results: QRS duration prolongs and heart rate decreases during the last 10 hours of life and the changes in these parameters were more prominent in the last hours. QRS duration increased at rate of 5.43 ms per hour (p<0.001) and heart rate decreased at rate of 2.68/min each hour (p<0.001). QRS amplitude attenuation were more subtle (decreased by 0.23 mV per hour, p=0.02) compared to QRS duration and heart rate. Conclusion: During last 10 hours of life, there was widening of QRS complex, attenuation of QRS voltage and decrease in heart rate. Automated softwares could present these findings in graphics and can be used as a prognostic indicators to recognize a dying patient. This information could be used in certain acute reversible critical conditions such as fulminant myocarditis, anaphylactic shock, trauma patients as a sign of poor prognosis or on decision making regarding end-of-life in irreversible illness such as terminal cancer patients.","PeriodicalId":39118,"journal":{"name":"Turkiye Klinikleri Cardiovascular Sciences","volume":"18 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Electrocardiographic Changes in Intensive Care Unit Patients During Their Last Hours of Life: Can We Use These Parameters as Prognostic Indicators?\",\"authors\":\"A. Paudel, O. Mammadov, E. Ekicibaşi, N. Mammadov, Ararso Kedir Jima\",\"doi\":\"10.5336/cardiosci.2020-74783\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"ABS TRACT Objective: QRS amplitude attenuation and prolonged QRS duration has been associated with increased mortality in various clinical conditions including critical care patients and general population. Relative bradycardia has been found to be associated with lower mortality in patients with septic shock, but there are no studies in literature evaluating the electrocardiographic (ECG) changes and changes in heart rate (HR) just before death. Our aim of this study is to calculate the gradual changes in these parameters in the last hours of life from II derivation telemetry records. Material and Methods: We included 30 patients who died in intensive care unit irrespective of their diagnosis during admission and follow up. HR, QRS amplitude and QRS duration were analysed from the telemetry recordings obtained from the last 10 hours of their life. Results: QRS duration prolongs and heart rate decreases during the last 10 hours of life and the changes in these parameters were more prominent in the last hours. QRS duration increased at rate of 5.43 ms per hour (p<0.001) and heart rate decreased at rate of 2.68/min each hour (p<0.001). QRS amplitude attenuation were more subtle (decreased by 0.23 mV per hour, p=0.02) compared to QRS duration and heart rate. Conclusion: During last 10 hours of life, there was widening of QRS complex, attenuation of QRS voltage and decrease in heart rate. Automated softwares could present these findings in graphics and can be used as a prognostic indicators to recognize a dying patient. This information could be used in certain acute reversible critical conditions such as fulminant myocarditis, anaphylactic shock, trauma patients as a sign of poor prognosis or on decision making regarding end-of-life in irreversible illness such as terminal cancer patients.\",\"PeriodicalId\":39118,\"journal\":{\"name\":\"Turkiye Klinikleri Cardiovascular Sciences\",\"volume\":\"18 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Turkiye Klinikleri Cardiovascular Sciences\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5336/cardiosci.2020-74783\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Turkiye Klinikleri Cardiovascular Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5336/cardiosci.2020-74783","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
摘要
目的:QRS振幅衰减和QRS持续时间延长与各种临床条件下的死亡率增加有关,包括重症监护患者和一般人群。已发现感染性休克患者的相对心动过缓与较低的死亡率相关,但尚未有文献研究评价死亡前心电图(ECG)变化和心率(HR)变化。我们这项研究的目的是计算这些参数在生命的最后几个小时从II衍生遥测记录的渐进变化。材料和方法:我们纳入了30例在重症监护病房死亡的患者,无论入院和随访期间是否确诊。从他们生命最后10小时的遥测记录中分析HR、QRS振幅和QRS持续时间。结果:QRS持续时间在生命的最后10小时延长,心率下降,且这些参数的变化在生命的最后10小时更为明显。QRS持续时间以5.43 ms / h的速率增加(p<0.001),心率以2.68 ms /min / h的速率降低(p<0.001)。与QRS持续时间和心率相比,QRS振幅衰减更细微(下降0.23 mV / h, p=0.02)。结论:在生命的最后10 h, QRS复合体增宽,QRS电压衰减,心率降低。自动化软件可以将这些发现以图形的形式呈现出来,并可以用作识别垂死病人的预后指标。这些信息可用于某些急性可逆性危重疾病,如暴发性心肌炎、过敏性休克、创伤患者,作为预后不良的标志,或用于不可逆性疾病(如晚期癌症患者)的临终决策。
Electrocardiographic Changes in Intensive Care Unit Patients During Their Last Hours of Life: Can We Use These Parameters as Prognostic Indicators?
ABS TRACT Objective: QRS amplitude attenuation and prolonged QRS duration has been associated with increased mortality in various clinical conditions including critical care patients and general population. Relative bradycardia has been found to be associated with lower mortality in patients with septic shock, but there are no studies in literature evaluating the electrocardiographic (ECG) changes and changes in heart rate (HR) just before death. Our aim of this study is to calculate the gradual changes in these parameters in the last hours of life from II derivation telemetry records. Material and Methods: We included 30 patients who died in intensive care unit irrespective of their diagnosis during admission and follow up. HR, QRS amplitude and QRS duration were analysed from the telemetry recordings obtained from the last 10 hours of their life. Results: QRS duration prolongs and heart rate decreases during the last 10 hours of life and the changes in these parameters were more prominent in the last hours. QRS duration increased at rate of 5.43 ms per hour (p<0.001) and heart rate decreased at rate of 2.68/min each hour (p<0.001). QRS amplitude attenuation were more subtle (decreased by 0.23 mV per hour, p=0.02) compared to QRS duration and heart rate. Conclusion: During last 10 hours of life, there was widening of QRS complex, attenuation of QRS voltage and decrease in heart rate. Automated softwares could present these findings in graphics and can be used as a prognostic indicators to recognize a dying patient. This information could be used in certain acute reversible critical conditions such as fulminant myocarditis, anaphylactic shock, trauma patients as a sign of poor prognosis or on decision making regarding end-of-life in irreversible illness such as terminal cancer patients.